T. .. Protocole,

. .. Protocole-de-rtms,

. .. Resultats, 44 3.2 Caractéristiques générales de la population

.. .. Caractéristiques-socio-démographiques,

.. .. Caractéristiques-cliniques-de-la-population,

. .. Caractéristiques-pharmacologiques,

. .. Réponse-au-traitement,

. .. Qualité-de-vie,

. .. Tolérance,

T. .. Analyses,

. .. Discussion,

L. .. , 59 4.3 Effets de la bobine Double-Cône (DC) sur le fonctionnement cérébral

?. .. Le-noyau-caudé-comme-marqueur-de-réponse-métabolique, , p.61

, Les modifications de la fonction cérébrale en rTMS standard et profonde, p.61

, Autres cibles et autres protocoles de stimulation

. .. La-bobine-de-stimulation,

. .. Conclusion,

. .. References,

. .. Annexe, somatiques ainsi que de prélever le matériel biologique des patients (CRP ultra-sensible, glycémie, hormones thyroïdiennes, marqueurs de l'inflammation, profil pharmacogénétique métabolique?) pour enrichir les bases de données, vol.87

, Site officiel de l'Organisation mondiale de la Santé

D. Sur,

M. T. Berlim, F. Van-den-eynde, S. Tovar-perdomo, and Z. J. Daskalakis, Response, remission and drop-out rates following high-frequency repetitive transcranial magnetic stimulation (rTMS) for treating major depression: a systematic review and meta-analysis of randomized, double-blind and sham-controlled trials, Psychol Med. janv, vol.44, issue.2, pp.225-264, 2014.

K. K. Kedzior, H. M. Gellersen, A. K. Brachetti, and M. T. Berlim, Deep transcranial magnetic stimulation (DTMS) in the treatment of major depression: An exploratory systematic review and meta-analysis, J Affect Disord, vol.187, pp.73-83, 2015.

J. Alonso, M. C. Angermeyer, S. Bernert, R. Bruffaerts, T. S. Brugha et al., Prevalence of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project, Acta Psychiatr Scand. 1 juin, vol.109, issue.s420, pp.21-28, 2004.

R. C. Kessler, S. Zhao, D. G. Blazer, and M. Swartz, Prevalence, correlates, and course of minor depression and major depression in the National Comorbidity Survey, J Affect Disord. août, vol.45, issue.1-2, pp.19-30, 1997.

G. Andrews, Should depression be managed as a chronic disease?, BMJ. 17 févr, vol.322, issue.7283, pp.419-440, 2001.

, DSM-5, p.12, 2018.

D. Sur,

J. Rush, A. Giles, D. E. Schlesser, M. A. Fulton, C. L. Weissenburger et al., The inventory for depressive symptomatology (IDS): Preliminary findings, Psychiatry Res. 1 mai, vol.18, issue.1, pp.65-87, 1986.

S. A. Montgomery and M. Asberg, A new depression scale designed to be sensitive to change, Br J Psychiatry J Ment Sci. avr, vol.134, pp.382-391, 1979.

M. Hamilton, Development of a rating scale for primary depressive illness, Br J Soc Clin Psychol. déc, vol.6, issue.4, pp.278-96, 1967.

A. J. Rush, M. H. Trivedi, H. M. Ibrahim, T. J. Carmody, B. Arnow et al., The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression, Biol Psychiatry. 1 sept, vol.54, issue.5, pp.573-83, 2003.

A. T. Beck, C. H. Ward, M. Mendelson, J. Mock, and J. Erbaugh, An inventory for measuring depression, Arch Gen Psychiatry. juin, vol.4, pp.561-71, 1961.

C. Schotte, B. Van-den-bossche, D. Doncker, D. Claes, S. Cosyns et al., A biopsychosocial model as a guide for psychoeducation and treatment of depression, Depress Anxiety, vol.23, issue.5, pp.312-336, 2006.

S. N. Ghaemi, The rise and fall of the biopsychosocial model, Br J Psychiatry J Ment Sci. juill, vol.195, issue.1, pp.3-4, 2009.

G. L. Engel, The need for a new medical model: a challenge for biomedicine, Science. 8 avr, vol.196, issue.4286, pp.129-165, 1977.

G. Papadimitriou, The « Biopsychosocial Model »: 40 years of application in Psychiatry, Psychiatr Psychiatr. juin, vol.28, issue.2, pp.107-117, 2017.

I. J. Selikoff, E. H. Robitzek, and G. G. Ornstein, Treatment of pulmonary tuberculosis with hydrazide derivatives of isonicotinic acid, J Am Med Assoc, vol.150, issue.10, pp.973-80, 1952.

R. Kuhn, The treatment of depressive states with G 22355 (imipramine hydrochloride)

, Am J Psychiatry, vol.115, issue.5, pp.459-64, 1958.

A. Coppen, The Biochemistry of Affective Disorders, Br J Psychiatry, vol.113, issue.504, pp.1237-64, 1967.

I. P. Lapin and G. F. Oxenkrug, Intensification of the central serotoninergic processes as a possible determinant of the thymoleptic effect, Lancet Lond Engl. 18 janv, vol.1, issue.7586, pp.132-138, 1969.

J. J. Schildkraut, The catecholamine hypothesis of affective disorders: A review of supporting evidence, Am J Psychiatry, vol.122, issue.5, pp.509-531, 1965.

S. Mulinari, Monoamine theories of depression: historical impact on biomedical research, J Hist Neurosci, vol.21, issue.4, pp.366-92, 2012.

D. Stahl, Stahl's Essential Psychopharmacology: Neuroscientific Basis and Practical Applications. 4th Edn

B. Liu, J. Liu, M. Wang, Y. Zhang, and L. Li, From Serotonin to Neuroplasticity: Evolvement of Theories for Major Depressive Disorder, Front Cell Neurosci, vol.11, p.305, 2017.

G. Feng, C. Kang, J. Yuan, Y. Zhang, Y. Wei et al., Neuroendocrine abnormalities associated with untreated first episode patients with major depressive disorder and bipolar disorder, Psychoneuroendocrinology. sept, vol.107, pp.119-142, 2019.

E. Og?odek, A. Szota, M. Just, D. Mo?, and A. Araszkiewicz, The role of the neuroendocrine and immune systems in the pathogenesis of depression, Pharmacol Rep PR, vol.66, issue.5, pp.776-81, 2014.

K. Wingenfeld and O. T. Wolf, Effects of cortisol on cognition in major depressive disorder, posttraumatic stress disorder and borderline personality disorder -2014 Curt Richter Award Winner, Psychoneuroendocrinology. janv, vol.51, pp.282-95, 2015.

K. Fountoulakis, S. Kantartzis, M. Siamouli, P. Panagiotidis, S. Kaprinis et al., Peripheral thyroid dysfunction in depression, World J Biol Psychiatry Off J World Fed Soc Biol Psychiatry. 1 févr, vol.7, pp.131-138, 2006.

P. Newhouse and A. K. Estrogen, Stress, and Depression: A Neurocognitive Model, JAMA Psychiatry. juill, vol.72, issue.7, pp.727-736, 2015.

J. C. Felger and F. E. Lotrich, Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications, Neuroscience. 29 août, vol.246, pp.199-229, 2013.

O. Kohler, J. Krogh, O. Mors, and M. E. Benros, Inflammation in Depression and the Potential for Anti-Inflammatory Treatment, Curr Neuropharmacol, vol.14, issue.7, pp.732-774, 2016.

B. E. Leonard, Inflammation and depression: a causal or coincidental link to the pathophysiology?, Acta Neuropsychiatr. févr, vol.30, issue.1, pp.1-16, 2018.

N. Zaki, D. W. Spence, A. S. Bahammam, S. R. Pandi-perumal, D. P. Cardinali et al., Chronobiological theories of mood disorder, Eur Arch Psychiatry Clin Neurosci. mars, vol.268, issue.2, pp.107-125, 2018.

D. Landgraf, M. J. Mccarthy, and D. K. Welsh, Circadian clock and stress interactions in the molecular biology of psychiatric disorders. Curr Psychiatry Rep, vol.16, p.483, 2014.

D. P. Cardinali, V. Srinivasan, A. Brzezinski, and G. M. Brown, Melatonin and its analogs in insomnia and depression, J Pineal Res. mai, vol.52, issue.4, pp.365-75, 2012.

S. Mouillet-richard, A. Baudry, J. Launay, and O. Kellermann, MicroRNAs and depression, Neurobiol Dis. mai, vol.46, issue.2, pp.272-280, 2012.

N. N. Karpova, Role of BDNF epigenetics in activity-dependent neuronal plasticity, Neuropharmacology. janv, vol.76, pp.709-727, 2014.

S. Moriam and M. E. Sobhani, Epigenetic effect of chronic stress on dopamine signaling and depression, Genet Epigenetics, vol.5, pp.11-17, 2013.

L. Booij, M. Szyf, A. Carballedo, E. Frey, D. Morris et al., DNA methylation of the serotonin transporter gene in peripheral cells and stress-related changes in hippocampal volume: a study in depressed patients and healthy controls, PloS One, vol.10, issue.3, p.119061, 2015.

E. M. Byrne, T. Carrillo-roa, A. K. Henders, L. Bowdler, A. F. Mcrae et al., Monozygotic twins affected with major depressive disorder have greater variance in methylation than their unaffected co-twin, Transl Psychiatry. 11 juin, vol.3, p.269, 2013.

M. Uddin, K. C. Koenen, A. E. Aiello, D. E. Wildman, R. De-los-santos et al., Epigenetic and inflammatory marker profiles associated with depression in a community-based epidemiologic sample, Psychol Med. mai, vol.41, issue.5, pp.997-1007, 2011.

S. Numata, K. Ishii, A. Tajima, J. Iga, M. Kinoshita et al., Blood diagnostic biomarkers for major depressive disorder using multiplex DNA methylation profiles: discovery and validation, Epigenetics, vol.10, issue.2, pp.135-176, 2015.

H. E. Covington, I. Maze, Q. C. Laplant, V. F. Vialou, Y. N. Ohnishi et al., Antidepressant actions of histone deacetylase inhibitors, J Neurosci Off J Soc Neurosci. 16 sept, vol.29, issue.37, pp.11451-60, 2009.

N. M. Tsankova, A. Kumar, and E. J. Nestler, Histone modifications at gene promoter regions in rat hippocampus after acute and chronic electroconvulsive seizures, J Neurosci Off J Soc Neurosci. 16 juin, vol.24, issue.24, pp.5603-5613, 2004.

W. Renthal, I. Maze, V. Krishnan, H. E. Covington, G. Xiao et al., Histone deacetylase 5 epigenetically controls behavioral adaptations to chronic emotional stimuli, Neuron, vol.56, issue.3, pp.517-546, 2007.

A. Serretti, M. Kato, D. Ronchi, D. Kinoshita, and T. , Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with selective serotonin reuptake inhibitor efficacy in depressed patients, Mol Psychiatry. mars, vol.12, issue.3, pp.247-57, 2007.

S. Porcelli, C. Fabbri, and A. Serretti, Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with antidepressant efficacy, Eur Neuropsychopharmacol J Eur Coll Neuropsychopharmacol. avr, vol.22, issue.4, pp.239-58, 2012.

R. C. Culverhouse, N. L. Saccone, A. C. Horton, Y. Ma, K. J. Anstey et al., Collaborative meta-analysis finds no evidence of a strong interaction between stress and 5-HTTLPR genotype contributing to the development of depression, Mol Psychiatry, vol.23, issue.1, pp.133-175, 2018.
URL : https://hal.archives-ouvertes.fr/hal-02355790

F. J. Mcmahon, S. Buervenich, D. Charney, R. Lipsky, A. J. Rush et al., Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment, Am J Hum Genet. mai, vol.78, issue.5, pp.804-818, 2006.

E. Bora, A. Fornito, C. Pantelis, and M. Yücel, Gray matter abnormalities in Major Depressive Disorder: a meta-analysis of voxel based morphometry studies, J Affect Disord. avr, vol.138, issue.1-2, pp.9-18, 2012.

V. Lorenzetti, N. B. Allen, A. Fornito, and M. Yücel, Structural brain abnormalities in major depressive disorder: a selective review of recent MRI studies, J Affect Disord. sept, vol.117, issue.1-2, pp.1-17, 2009.

Y. Zhao, M. Du, X. Huang, S. Lui, Z. Chen et al., Brain grey matter abnormalities in medication-free patients with major depressive disorder: a metaanalysis, Psychol Med, vol.44, issue.14, pp.2927-2964, 2014.

E. Fallucca, F. P. Macmaster, J. Haddad, P. Easter, R. Dick et al., Distinguishing between major depressive disorder and obsessive-compulsive disorder in children by measuring regional cortical thickness, Arch Gen Psychiatry. mai, vol.68, issue.5, pp.527-560, 2011.

M. U. Shad, S. Muddasani, and U. Rao, Gray Matter Differences Between Healthy and Depressed Adolescents: A Voxel-Based Morphometry Study, J Child Adolesc Psychopharmacol. juin, vol.22, issue.3, pp.190-197, 2012.

L. Schmaal, D. P. Hibar, P. G. Sämann, G. B. Hall, B. T. Baune et al., Cortical abnormalities in adults and adolescents with major depression based on brain scans from 20 cohorts worldwide in the ENIGMA Major Depressive Disorder Working Group, Mol Psychiatry, vol.22, issue.6, pp.900-909, 2017.

. Baxter-null, . Saxena-null, A. Brody-null, C. Null, . Null et al., Brain Mediation of Obsessive-Compulsive Disorder Symptoms: Evidence From, vol.75

, Functional Brain Imaging Studies in the Human and Nonhuman Primate, Semin Clin Neuropsychiatry. janv, vol.1, issue.1, pp.32-47, 1996.

R. J. Davidson, W. Irwin, M. J. Anderle, and N. H. Kalin, The neural substrates of affective processing in depressed patients treated with venlafaxine, Am J Psychiatry. janv, vol.160, issue.1, pp.64-75, 2003.

A. L. Brody, S. Saxena, M. A. Mandelkern, L. A. Fairbanks, M. L. Ho et al., Brain metabolic changes associated with symptom factor improvement in major depressive disorder, Biol Psychiatry. 1 août, vol.50, issue.3, pp.171-179, 2001.

W. C. Drevets, J. L. Price, M. E. Bardgett, T. Reich, R. D. Todd et al., Glucose metabolism in the amygdala in depression: relationship to diagnostic subtype and plasma cortisol levels, Pharmacol Biochem Behav. mars, vol.71, issue.3, pp.431-478, 2002.

W. C. Drevets, J. L. Price, and M. L. Furey, Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression, Brain Struct Funct. sept, vol.213, issue.1-2, pp.93-118, 2008.

W. C. Drevets, Neuroimaging and neuropathological studies of depression: implications for the cognitive-emotional features of mood disorders, Curr Opin Neurobiol. avr, vol.11, issue.2, pp.240-249, 2001.

J. P. Hamilton, A. Etkin, D. J. Furman, M. G. Lemus, R. F. Johnson et al., Functional neuroimaging of major depressive disorder: a meta-analysis and new integration of base line activation and neural response data, Am J Psychiatry. juill, vol.169, issue.7, pp.693-703, 2012.

L. Su, Y. Cai, Y. Xu, A. Dutt, S. Shi et al., Cerebral metabolism in major depressive disorder: a voxel-based meta-analysis of positron emission tomography studies, BMC Psychiatry, vol.14, 2014.

C. J. Bench, K. J. Friston, R. G. Brown, R. S. Frackowiak, and R. J. Dolan, Regional cerebral blood flow in depression measured by positron emission tomography: the relationship with clinical dimensions, Psychol Med. août, vol.23, issue.3, 1993.

D. Sur,

H. S. Mayberg, Positron emission tomography imaging in depression: a neural systems perspective, Neuroimaging Clin N Am, vol.13, issue.4, pp.805-820, 2003.

S. G. Disner, C. G. Beevers, E. Haigh, and A. T. Beck, Neural mechanisms of the cognitive model of depression, Nat Rev Neurosci, vol.06, issue.8, pp.467-77, 2011.

K. Zhang, Y. Zhu, Y. Zhu, S. Wu, H. Liu et al., Molecular, Functional, and Structural Imaging of Major Depressive Disorder, Neurosci Bull. 3 mai, vol.32, issue.3, pp.273-85, 2016.

R. J. Anderson, K. E. Hoy, Z. J. Daskalakis, and P. B. Fitzgerald, Repetitive transcranial magnetic stimulation for treatment resistant depression: Re-establishing connections, Clin Neurophysiol Off J Int Fed Clin Neurophysiol, vol.127, issue.11, pp.3394-405, 2016.

M. D. Fox, A. Z. Snyder, J. L. Vincent, M. Corbetta, D. C. Van-essen et al., The human brain is intrinsically organized into dynamic, anticorrelated functional networks, Proc Natl Acad Sci U S A. 5 juill, vol.102, issue.27, pp.9673-9681, 2005.

M. A. Rogers, K. Kasai, M. Koji, R. Fukuda, A. Iwanami et al., Executive and prefrontal dysfunction in unipolar depression: a review of neuropsychological and imaging evidence, Neurosci Res. sept, vol.50, issue.1, pp.1-11, 2004.

P. C. Mulders, P. F. Van-eijndhoven, A. H. Schene, C. F. Beckmann, and I. Tendolkar, Resting-state functional connectivity in major depressive disorder: A review, Neurosci Biobehav Rev. sept, vol.56, pp.330-374, 2015.

. Nimh-»-research-domain and . Criteria, , 2019.

D. Sur,

B. N. Cuthbert and T. R. Insel, Toward the future of psychiatric diagnosis: the seven pillars of RDoC, BMC Med. 14 mai, vol.11, p.126, 2013.

M. T. Berlim and G. Turecki, What is the meaning of treatment resistant/refractory major depression (TRD)? A systematic review of current randomized trials, Eur Neuropsychopharmacol J Eur Coll Neuropsychopharmacol, vol.17, issue.11, pp.696-707, 2007.

J. Holtzmann, R. Richieri, G. Saba, N. Allaïli, R. Bation et al., Quelle définition pour la dépression résistante ?, Presse Médicale. 1 mars, vol.45, issue.3, pp.323-331, 2016.

C. Yang, K. J. Wardenaar, F. J. Bosker, J. Li, and R. A. Schoevers, Inflammatory markers and treatment outcome in treatment resistant depression: A systematic review, J Affect Disord, vol.257, pp.640-649, 2019.

D. G. Dillon, R. Bogdan, J. Fagerness, A. J. Holmes, R. H. Perlis et al., Variation in TREK1 gene linked to depression-resistant phenotype is associated with potentiated neural responses to rewards in humans, Hum Brain Mapp. févr, vol.31, issue.2, pp.210-231, 2010.

K. Hodgson, K. Tansey, M. Z. Dernovsek, J. Hauser, N. Henigsberg et al., Genetic differences in cytochrome P450 enzymes and antidepressant treatment response, J Psychopharmacol Oxf Engl. févr, vol.28, issue.2, pp.133-174, 2014.

T. Yamamura, Y. Okamoto, G. Okada, Y. Takaishi, M. Takamura et al., Association of thalamic hyperactivity with treatment-resistant depression and poor response in early treatment for major depression: a resting-state fMRI study using fractional amplitude of low-frequency fluctuations, Transl Psychiatry. mars, vol.6, issue.3, p.754, 2016.

R. Richieri, L. Boyer, C. Faget-agius, J. Farisse, O. Mundler et al., Determinants of brain SPECT perfusion and connectivity in treatment-resistant depression, Psychiatry Res. 28 févr, vol.231, issue.2, pp.134-174, 2015.

, Frontal alpha asymmetry as a diagnostic marker in depression: Fact or fiction? A metaanalysis

D. Sur,

M. E. Thase and A. J. Rush, When at first you don't succeed: sequential strategies for antidepressant nonresponders, J Clin Psychiatry, vol.58, issue.13, pp.23-32, 1997.

H. G. Ruhé, G. Van-rooijen, J. Spijker, F. Peeters, and A. H. Schene, Staging methods for treatment resistant depression. A systematic review, J Affect Disord. mars, vol.137, issue.1-3, pp.35-45, 2012.

A. Fekadu, J. G. Donocik, and A. J. Cleare, Standardisation framework for the Maudsley staging method for treatment resistance in depression, BMC Psychiatry, vol.11, issue.1, p.100, 2018.

A. Fekadu, S. C. Wooderson, K. Markopoulou, and A. J. Cleare, The Maudsley Staging Method for treatment-resistant depression: prediction of longer-term outcome and persistence of symptoms, J Clin Psychiatry. juill, vol.70, issue.7, pp.952-959, 2009.

, Depression in adults: treatment and management | Guidance and guidelines | NICE

D. Sur,

B. Bandelow, L. Sher, R. Bunevicius, E. Hollander, S. Kasper et al., Guidelines for the pharmacological treatment of anxiety disorders, obsessive-compulsive disorder and posttraumatic stress disorder in primary care, Int J Psychiatry Clin Pract. juin, vol.16, issue.2, pp.77-84, 2012.

S. H. Kennedy, R. W. Lam, R. S. Mcintyre, S. V. Tourjman, V. Bhat et al., Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder, Can J Psychiatry Rev Can Psychiatr. sept, vol.61, issue.9, pp.540-60, 2016.

J. Jiang, J. Wang, and C. Li, Potential Mechanisms Underlying the Therapeutic Effects of Electroconvulsive Therapy, Neurosci Bull. 28 déc, vol.33, issue.3, pp.339-386, 2016.

N. Khalid, M. Atkins, J. Tredget, M. Giles, K. Champney-smith et al., The effectiveness of electroconvulsive therapy in treatment-resistant depression: a naturalistic study, J ECT. juin, vol.24, issue.2, pp.141-146, 2008.

K. A. Leiknes, L. Jarosh-von-schweder, and B. Høie, Contemporary use and practice of electroconvulsive therapy worldwide, Brain Behav. mai, vol.2, issue.3, pp.283-344, 2012.

S. M. Berry, K. Broglio, M. Bunker, A. Jayewardene, B. Olin et al., A patient-level meta-analysis of studies evaluating vagus nerve stimulation therapy for treatmentresistant depression, Med Devices Auckl NZ, vol.6, pp.17-35, 2013.

M. T. Bilge, A. K. Gosai, and A. S. Widge, Deep Brain Stimulation in Psychiatry: Mechanisms, Models, and Next-Generation Therapies, Psychiatr Clin North Am. sept, vol.41, issue.3, pp.373-83, 2018.

P. B. Fitzgerald and R. A. Segrave, Deep brain stimulation in mental health: Review of evidence for clinical efficacy, Aust N Z J Psychiatry, vol.49, issue.11, pp.979-93, 2015.

S. Van-bronswijk, N. Moopen, L. Beijers, H. G. Ruhe, and F. Peeters, Effectiveness of psychotherapy for treatment-resistant depression: a meta-analysis and meta-regression

, Psychol Med. févr, vol.49, issue.3, pp.366-79, 2019.

A. T. Barker, R. Jalinous, and I. L. Freeston, Non-invasive magnetic stimulation of human motor cortex, Lancet Lond Engl. 11 mai, vol.1, issue.8437, pp.1106-1113, 1985.

F. Etcheverrigaray, B. Samuel, L. Machon, V. Riche, N. Mauduit et al., Traitement de la dépression par stimulation magnétique transcrânienne (rTMS) : quelles pistes pour le remboursement d'une activité de pointe en psychiatrie ?, Rev DÉpidémiologie Santé Publique. 1 mars, vol.65, 2017.

Z. Deng, S. H. Lisanby, and A. V. Peterchev, Electric field depth-focality tradeoff in transcranial magnetic stimulation: simulation comparison of 50 coil designs, Brain Stimulat. janv, vol.6, issue.1, pp.1-13, 2013.

L. G. Cohen, B. J. Roth, J. Nilsson, N. Dang, M. Panizza et al., Effects of coil design on delivery of focal magnetic stimulation, Electroencephalogr Clin Neurophysiol. avr, vol.75, issue.4, pp.350-357, 1990.

S. Ueno, T. Tashiro, and K. Harada, Localized stimulation of neural tissues in the brain by means of a paired configuration of time-varying magnetic fields, J Appl Phys, vol.15, issue.10, pp.5862-5866, 1988.

T. Perera, M. S. George, G. Grammer, P. G. Janicak, A. Pascual-leone et al., The Clinical TMS Society Consensus Review and Treatment Recommendations for TMS Therapy for Major Depressive Disorder, Brain Stimulat, vol.9, issue.3, pp.336-382, 2016.

A. Valero-cabré, A. Pascual-leone, and O. A. Coubard, Transcranial magnetic stimulation (TMS) in basic and clinical neuroscience research

, Rev Neurol (Paris). avr, vol.167, issue.4, pp.291-316, 2011.

M. Lu and S. Ueno, Comparison of the induced fields using different coil configurations during deep transcranial magnetic stimulation, Disponible sur, vol.12, 2017.

S. W. Chung, K. E. Hoy, and P. B. Fitzgerald, Theta-burst stimulation: a new form of TMS treatment for depression?, Depress Anxiety. mars, vol.32, issue.3, pp.182-92, 2015.

Y. Huang, M. J. Edwards, E. Rounis, K. P. Bhatia, and J. C. Rothwell, Theta burst stimulation of the human motor cortex, Neuron. 20 janv, vol.45, issue.2, pp.201-207, 2005.

K. Nakamura, S. J. Groiss, M. Hamada, H. Enomoto, S. Kadowaki et al., Variability in Response to Quadripulse Stimulation of the Motor Cortex, Brain Stimulat. déc, vol.9, issue.6, pp.859-66, 2016.

S. Rossi, M. Hallett, P. M. Rossini, and A. Pascual-leone, Safety of TMS Consensus Group. Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research, Clin Neurophysiol Off J Int Fed Clin Neurophysiol. déc, vol.120, issue.12, pp.2008-2047, 2009.

T. Hsieh, S. C. Dhamne, J. Chen, L. L. Carpenter, E. M. Anastasio et al., Minimal heating of aneurysm clips during repetitive transcranial magnetic stimulation, Clin Neurophysiol Off J Int Fed Clin Neurophysiol. juill, vol.123, issue.7, pp.1471-1474, 2012.

S. M. Mcclintock, I. M. Reti, L. L. Carpenter, W. M. Mcdonald, M. Dubin et al., Consensus Recommendations for the Clinical Application of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Depression, Disponible sur, vol.79

A. Pascual-leone, J. Valls-solé, E. M. Wassermann, and M. Hallett, Responses to rapid-rate transcranial magnetic stimulation of the human motor cortex, Brain J Neurol. août, vol.117, pp.847-58, 1994.

R. Richieri, L. Boyer, R. Padovani, M. Adida, C. Colavolpe et al., Equivalent brain SPECT perfusion changes underlying therapeutic efficiency in pharmacoresistant depression using either high-frequency left or low-frequency right prefrontal rTMS, Prog Neuropsychopharmacol Biol Psychiatry. 3 déc, vol.39, issue.2, pp.364-70, 2012.

M. S. George, E. M. Wassermann, and R. M. Post, Transcranial magnetic stimulation: a neuropsychiatric tool for the 21st century, J Neuropsychiatry Clin Neurosci, vol.8, issue.4, pp.373-82, 1996.

F. M. Mottaghy, C. E. Keller, M. Gangitano, J. Ly, M. Thall et al., Correlation of cerebral blood flow and treatment effects of repetitive transcranial magnetic stimulation in depressed patients, Psychiatry Res. 20 août, vol.115, issue.1-2, pp.1-14, 2002.

A. M. Speer, T. A. Kimbrell, E. M. Wassermann, J. Repella, M. W. Willis et al., Opposite effects of high and low frequency rTMS on regional brain activity in depressed patients, Biol Psychiatry. 15 déc, vol.48, issue.12, pp.1133-1174, 2000.

C. C. Teneback, Z. Nahas, A. M. Speer, M. Molloy, L. E. Stallings et al., Changes in prefrontal cortex and paralimbic activity in depression following two weeks of daily left prefrontal TMS, J Neuropsychiatry Clin Neurosci, vol.11, issue.4, pp.426-461, 1999.

T. Paus, P. K. Sipila, and A. P. Strafella, Synchronization of neuronal activity in the human primary motor cortex by transcranial magnetic stimulation: an EEG study, J Neurophysiol, vol.86, issue.4, pp.1983-90, 2001.

S. Kito, T. Hasegawa, and Y. Koga, Neuroanatomical correlates of therapeutic efficacy of lowfrequency right prefrontal transcranial magnetic stimulation in treatment-resistant depression, Psychiatry Clin Neurosci. mars, vol.65, issue.2, pp.175-82, 2011.

E. K. Silberman and H. Weingartner, Hemispheric lateralization of functions related to emotion, Brain Cogn. juill, vol.5, issue.3, pp.322-53, 1986.

T. Paus and J. Barrett, Transcranial magnetic stimulation (TMS) of the human frontal cortex: implications for repetitive TMS treatment of depression, J Psychiatry Neurosci. juill, vol.29, issue.4, pp.268-79, 2004.

P. B. Fitzgerald, S. Fountain, and Z. J. Daskalakis, A comprehensive review of the effects of rTMS on motor cortical excitability and inhibition, Clin Neurophysiol Off J Int Fed Clin Neurophysiol. déc, vol.117, issue.12, pp.2584-96, 2006.

C. K. Loo, P. B. Mitchell, V. M. Croker, G. S. Malhi, W. Wen et al., Double-blind controlled investigation of bilateral prefrontal transcranial magnetic stimulation for the treatment of resistant major depression, Psychol Med. janv, vol.33, issue.1, pp.33-40, 2003.

P. Martinot, M. Galinowski, A. Ringuenet, D. Gallarda, T. Lefaucheur et al., Influence of prefrontal target region on the efficacy of repetitive transcranial magnetic stimulation in patients with medication-resistant depression: a [(18)F]-fluorodeoxyglucose PET and MRI study, Int J Neuropsychopharmacol. févr, vol.13, issue.1, pp.45-59, 2010.

B. Dell'osso, S. Zanoni, R. Ferrucci, M. Vergari, F. Castellano et al., Transcranial direct current stimulation for the outpatient treatment of poor-responder depressed patients, Eur Psychiatry J Assoc Eur Psychiatr, vol.27, issue.7, pp.513-520, 2012.

M. Gross, L. Nakamura, A. Pascual-leone, and F. Fregni, Has repetitive transcranial magnetic stimulation (rTMS) treatment for depression improved? A systematic review and metaanalysis comparing the recent vs. the earlier rTMS studies, Acta Psychiatr Scand. sept, vol.116, issue.3, pp.165-73, 2007.

M. T. Berlim, F. Van-den-eynde, and Z. J. Daskalakis, Efficacy and acceptability of high frequency repetitive transcranial magnetic stimulation (rTMS) versus electroconvulsive therapy (ECT) for major depression: a systematic review and meta-analysis of randomized trials, Depress Anxiety. juill, vol.30, issue.7, pp.614-637, 2013.

P. Zwanzger, T. C. Baghai, F. Padberg, R. Ella, C. Minov et al., The combined dexamethasone-CRH test before and after repetitive transcranial magnetic stimulation (rTMS) in major depression, Psychoneuroendocrinology. 1 avr, vol.28, issue.3, pp.376-85, 2003.

W. K. Silverstein, Y. Noda, M. S. Barr, F. Vila-rodriguez, T. K. Rajji et al., DEPRESSION: A SYSTEMATIC REVIEW. Depress Anxiety. déc, vol.32, issue.12, pp.871-91, 2015.

M. Martinot, J. Martinot, D. Ringuenet, A. Galinowski, T. Gallarda et al., Baseline Brain Metabolism in Resistant Depression and Response to Transcranial Magnetic Stimulation, Neuropsychopharmacology. déc, vol.36, issue.13, pp.2710-2719, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00671239

R. Richieri, L. Boyer, J. Farisse, C. Colavolpe, O. Mundler et al., Predictive value of brain perfusion SPECT for rTMS response in pharmacoresistant depression, Eur J Nucl Med Mol Imaging. sept, vol.38, issue.9, pp.1715-1737, 2011.

D. C. Monteiro and A. Cantilino, Use of a Double-Cone Coil in Transcranial Magnetic Stimulation for Depression Treatment, Neuromodulation J Int Neuromodulation Soc. 2 déc, 2018.

P. M. Kreuzer, J. Downar, D. De-ridder, J. Schwarzbach, M. Schecklmann et al., A Comprehensive Review of Dorsomedial Prefrontal Cortex rTMS Utilizing a Double Cone Coil, Neuromodulation J Int Neuromodulation Soc, 2018.

S. Zibman, G. S. Pell, N. Barnea-ygael, Y. Roth, and A. Zangen, Application of transcranial magnetic stimulation for major depression: Coil design and neuroanatomical variability considerations, Eur Neuropsychopharmacol J Eur Coll Neuropsychopharmacol. 5 juill, 2019.

I. Filip?i?, ?. Filip?i?, I. Milovac, ?. Su?i?, S. Gaj?ak et al., Efficacy of repetitive transcranial magnetic stimulation using a figure-8-coil or an H1-Coil in treatment of major depressive disorder; A randomized clinical trial, J Psychiatr Res. juill, vol.114, pp.113-122, 2019.

P. M. Kreuzer, M. Schecklmann, A. Lehner, T. C. Wetter, T. B. Poeppl et al., The ACDC Pilot Trial: Targeting the Anterior Cingulate by Double Cone Coil rTMS for the Treatment of Depression, Brain Stimul Basic Transl Clin Res Neuromodulation. 1 mars, vol.8, issue.2, pp.240-246, 2015.

L. Schulze, S. Wheeler, M. P. Mcandrews, C. Solomon, P. Giacobbe et al., Cognitive safety of dorsomedial prefrontal repetitive transcranial magnetic stimulation in major depression, Eur Neuropsychopharmacol J Eur Coll Neuropsychopharmacol, vol.26, issue.7, pp.1213-1239, 2016.

L. Schulze, K. Feffer, C. Lozano, P. Giacobbe, Z. J. Daskalakis et al., Number of pulses or number of sessions? An open-label study of trajectories of improvement for once-vs. twice-daily dorsomedial prefrontal rTMS in major depression, Brain Stimulat. avr, vol.11, issue.2, pp.327-363, 2018.

T. V. Salomons, K. Dunlop, S. H. Kennedy, A. Flint, J. Geraci et al., Resting-State Cortico-Thalamic-Striatal Connectivity Predicts Response to Dorsomedial Prefrontal rTMS in Major Depressive Disorder, Neuropsychopharmacology. janv, vol.39, issue.2, pp.488-98, 2014.

N. Bakker, S. Shahab, P. Giacobbe, D. M. Blumberger, Z. J. Daskalakis et al., rTMS of the Dorsomedial Prefrontal Cortex for Major Depression: Safety, Tolerability, Effectiveness, and Outcome Predictors for 10 Hz Versus Intermittent Theta-burst Stimulation, Brain Stimulat. 1 mars, vol.8, issue.2, pp.208-223, 2015.

A. Nordenskjöld, B. Mårtensson, A. Pettersson, E. Heintz, and M. Landén, Effects of Hesel-coil deep transcranial magnetic stimulation for depression -a systematic review, Nord J Psychiatry, vol.70, issue.7, pp.492-499, 2016.

C. J. Hawley, T. M. Gale, and T. Sivakumaran, Hertfordshire Neuroscience Research group. Defining remission by cut off score on the MADRS: selecting the optimal value, J Affect Disord, vol.72, issue.2, pp.177-84, 2002.

O. Lingjaerde, U. G. Ahlfors, P. Bech, S. J. Dencker, and K. Elgen, The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients, Acta Psychiatr Scand Suppl, vol.334, pp.1-100, 1987.

N. Smailagic, M. Vacante, C. Hyde, S. Martin, O. Ukoumunne et al., 18 F-FDG PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI), Cochrane Database Syst Rev. 28 janv, vol.1, p.10632, 2015.

Y. Yuan, Z. Gu, and W. Wei, Fluorodeoxyglucose-Positron-Emission Tomography, Single-Photon Emission Tomography, and Structural MR Imaging for Prediction of Rapid Conversion to Alzheimer Disease in Patients with Mild Cognitive Impairment: A Meta-Analysis, Am J Neuroradiol. 1 févr, vol.30, issue.2, pp.404-414, 2009.

E. L. Ergün, S. Saygi, D. Yalnizoglu, K. K. Oguz, and B. Erbas, SPECT-PET in Epilepsy and Clinical Approach in Evaluation, Semin Nucl Med, vol.46, issue.4, pp.294-307, 2016.

W. H. Theodore, Presurgical Focus Localization in Epilepsy: PET and SPECT, Semin Nucl Med. janv, vol.47, issue.1, pp.44-53, 2017.

J. Novy, G. Allenbach, C. G. Bien, E. Guedj, J. O. Prior et al., FDG-PET hyperactivity pattern in anti-NMDAr encephalitis, J Neuroimmunol, vol.15, pp.156-164, 2016.

L. B. Solnes, K. M. Jones, S. P. Rowe, P. Pattanayak, A. Nalluri et al., Diagnostic Value of 18F-FDG PET/CT Versus MRI in the Setting of Antibody-Specific Autoimmune Encephalitis, J Nucl Med Off Publ Soc Nucl Med, vol.58, issue.8, pp.1307-1320, 2017.

W. Chen, Clinical applications of PET in brain tumors, J Nucl Med Off Publ Soc Nucl Med. sept, vol.48, issue.9, pp.1468-81, 2007.

B. D. Power, T. Nguyen, B. Hayhow, and J. Looi, Neuroimaging in psychiatry: an update on neuroimaging in the clinical setting, Australas Psychiatry Bull R Aust N Z Coll Psychiatr. avr, vol.24, issue.2, pp.157-63, 2016.

N. Yahata, K. Kasai, and M. Kawato, Computational neuroscience approach to biomarkers and treatments for mental disorders, Psychiatry Clin Neurosci. avr, vol.71, issue.4, pp.215-252, 2017.

T. M. Fonseka, G. M. Macqueen, and S. H. Kennedy, Neuroimaging biomarkers as predictors of treatment outcome in Major Depressive Disorder, J Affect Disord, vol.233, pp.21-35, 2018.

M. Signorini, E. Paulesu, K. Friston, D. Perani, A. Colleluori et al., Rapid assessment of regional cerebral metabolic abnormalities in single subjects with quantitative and nonquantitative [18F]FDG PET: A clinical validation of statistical parametric mapping, NeuroImage. janv, vol.9, issue.1, pp.63-80, 1999.

R. Richieri, E. Guedj, P. Michel, A. Loundou, P. Auquier et al., Maintenance transcranial magnetic stimulation reduces depression relapse: A propensity-adjusted analysis, J Affect Disord. 18 juin, p.151, 2013.

R. Ahdab, S. S. Ayache, P. Brugières, C. Goujon, and J. Lefaucheur, Comparison of « standard » and « navigated » procedures of TMS coil positioning over motor, premotor and prefrontal targets in patients with chronic pain and depression, Neurophysiol Clin Clin Neurophysiol. mars, vol.40, issue.1, pp.27-36, 2010.

C. Schönfeldt-lecuona, J. Lefaucheur, L. Cardenas-morales, R. C. Wolf, T. Kammer et al., The value of neuronavigated rTMS for the treatment of depression, Neurophysiol Clin Clin Neurophysiol. mars, vol.40, issue.1, pp.37-43, 2010.

P. Julkunen, L. Säisänen, N. Danner, E. Niskanen, T. Hukkanen et al., Comparison of navigated and non-navigated transcranial magnetic stimulation for motor cortex mapping, motor threshold and motor evoked potentials, NeuroImage. 1 févr, vol.44, issue.3, pp.790-795, 2009.

J. Mollon, S. R. Mathias, E. Knowles, A. Rodrigue, M. Koenis et al., Cognitive impairment from early to middle adulthood in patients with affective and nonaffective psychotic disorders, Psychol Med. 4 janv, pp.1-10, 2019.

M. J. Weightman, T. M. Air, and B. T. Baune, A review of the role of social cognition in major depressive disorder, Front Psychiatry, vol.5, p.179, 2014.

S. S. Morimoto, D. Kanellopoulos, K. J. Manning, and G. S. Alexopoulos, Diagnosis and treatment of depression and cognitive impairment in late life, Ann N Y Acad Sci. mai, vol.1345, pp.36-46, 2015.

H. M. Gellersen and K. K. Kedzior, Antidepressant outcomes of high-frequency repetitive transcranial magnetic stimulation (rTMS) with F8-coil and deep transcranial magnetic stimulation (DTMS) with H1-coil in major depression: a systematic review and metaanalysis, BMC Psychiatry. 7 mai, vol.19, issue.1, p.139, 2019.

J. Downar, J. Geraci, T. V. Salomons, K. Dunlop, S. Wheeler et al., Anhedonia and reward-circuit connectivity distinguish nonresponders from responders to dorsomedial prefrontal repetitive transcranial magnetic stimulation in major depression, Biol Psychiatry. 1 août, vol.76, issue.3, pp.176-85, 2014.

C. Baeken, R. De-raedt, C. Van-hove, P. Clerinx, D. Mey et al., HF-rTMS treatment in medication-resistant melancholic depression: results from 18FDG-PET brain imaging, CNS Spectr. août, vol.14, issue.8, pp.439-487, 2009.

C. Li, S. Wang, J. Hirvonen, J. Hsieh, Y. Bai et al., Antidepressant mechanism of add-on repetitive transcranial magnetic stimulation in medication-resistant depression using cerebral glucose metabolism, J Affect Disord. déc, vol.127, issue.1-3, pp.219-248, 2010.

H. C. Lou, B. Luber, M. Crupain, J. P. Keenan, M. Nowak et al., Parietal cortex and representation of the mental Self, Proc Natl Acad Sci U S A. 27 avr, vol.101, issue.17, pp.6827-6859, 2004.

E. Bruner, T. M. Preuss, X. Chen, and J. K. Rilling, Evidence for expansion of the precuneus in human evolution, Brain Struct Funct, vol.222, issue.2, pp.1053-60, 2017.

K. Teffer and K. Semendeferi, Human prefrontal cortex: evolution, development, and pathology, Prog Brain Res, vol.195, pp.191-218, 2012.

Y. Shi, J. Li, Z. Feng, H. Xie, J. Duan et al., Abnormal functional connectivity strength in first-episode, drug-naïve adult patients with major depressive disorder, Prog Neuropsychopharmacol Biol Psychiatry. 6 sept, p.109759, 2019.

R. Dumas, R. Richieri, E. Guedj, P. Auquier, C. Lancon et al., Improvement of healthrelated quality of life in depression after transcranial magnetic stimulation in a naturalistic trial is associated with decreased perfusion in precuneus, Health Qual Life Outcomes. 28 juill, vol.10, p.87, 2012.

F. Zhang, W. Peng, J. A. Sweeney, Z. Jia, and Q. Gong, Brain structure alterations in depression: Psychoradiological evidence, CNS Neurosci Ther. 5 mars, vol.24, issue.11, pp.994-1003, 2018.

H. Peng, K. Wu, J. Li, H. Qi, S. Guo et al., Increased suicide attempts in young depressed patients with abnormal temporal-parietal-limbic gray matter volume, J Affect Disord. août, vol.165, pp.69-73, 2014.

S. Wei, M. Chang, R. Zhang, X. Jiang, F. Wang et al., Amygdala functional connectivity in female patients with major depressive disorder with and without suicidal ideation

, Ann Gen Psychiatry, vol.17, p.37, 2018.

C. Baeken, Accelerated rTMS: A Potential Treatment to Alleviate Refractory Depression, Front Psychol, vol.9, 2017.

A. F. Leuchter, I. A. Cook, D. Feifel, J. W. Goethe, M. Husain et al., Efficacy and Safety of Low-field Synchronized Transcranial Magnetic Stimulation (sTMS) for Treatment of Major Depression, Brain Stimulat. août, vol.8, issue.4, pp.787-94, 2015.

P. B. Fitzgerald, K. Hoy, S. Mcqueen, S. Herring, R. Segrave et al., Priming stimulation enhances the effectiveness of low-frequency right prefrontal cortex transcranial magnetic stimulation in major depression, J Clin Psychopharmacol. févr, vol.28, issue.1, pp.52-60, 2008.

A. R. Brunoni, A. Chaimani, A. H. Moffa, L. B. Razza, W. F. Gattaz et al., Repetitive Transcranial Magnetic Stimulation for the Acute Treatment of Major Depressive Episodes: A Systematic Review With Network Meta-analysis, JAMA Psychiatry. 1 févr, vol.74, issue.2, pp.143-52, 2017.

Z. Deng, S. H. Lisanby, and A. V. Peterchev, Coil Design Considerations for Deep Transcranial Magnetic Stimulation, Clin Neurophysiol Off J Int Fed Clin Neurophysiol. juin, vol.125, issue.6, pp.1202-1214, 2014.

K. K. Kedzior, L. Gierke, H. M. Gellersen, and M. T. Berlim, Cognitive functioning and deep transcranial magnetic stimulation (DTMS) in major psychiatric disorders: A systematic review, J Psychiatr Res. avr, vol.75, pp.107-122, 2016.

K. K. Kedzior, M. Schuchinsky, I. Gerkensmeier, and C. Loo, Challenges in comparing the acute cognitive outcomes of high-frequency repetitive transcranial magnetic stimulation (HF-rTMS) vs. electroconvulsive therapy (ECT) in major depression: A systematic review, J Psychiatr Res, vol.91, pp.14-21, 2017.

D. S. Cha, N. E. Carmona, M. Subramaniapillai, R. B. Mansur, Y. Lee et al., Cognitive impairment as measured by the THINC-integrated tool (THINC-it): Association with psychosocial function in major depressive disorder, J Affect Disord, vol.222, pp.14-20, 2017.

L. Culpepper, R. W. Lam, and R. S. Mcintyre, Cognitive Impairment in Patients With Depression: Awareness, Assessment, and Management, J Clin Psychiatry. déc, vol.78, issue.9, pp.1383-94, 2017.

A. Mcgirr, F. Van-den-eynde, S. Tovar-perdomo, M. Fleck, and M. T. Berlim, Effectiveness and acceptability of accelerated repetitive transcranial magnetic stimulation (rTMS) for treatment-resistant major depressive disorder: an open label trial, J Affect Disord. 1 mars, vol.173, pp.216-236, 2015.

M. Herr, J. Robine, J. Pinot, J. Arvieu, and J. Ankri, Polypharmacy and frailty: prevalence, relationship, and impact on mortality in a French sample of 2350 old people, Pharmacoepidemiol Drug Saf. juin, vol.24, issue.6, pp.637-683, 2015.
URL : https://hal.archives-ouvertes.fr/hal-02006072

L. Morin, K. Johnell, M. Laroche, J. Fastbom, and J. W. Wastesson, The epidemiology of polypharmacy in older adults: register-based prospective cohort study, Clin Epidemiol, vol.10, pp.289-98, 2018.

J. Ankri, Le risque iatrogène médicamenteux chez le sujet âgé, Gerontol Soc, vol.25, issue.4, pp.93-106, 2002.

I. Aguirre, B. Carretero, O. Ibarra, J. Kuhalainen, J. Martínez et al., Age predicts low-frequency transcranial magnetic stimulation efficacy in major depression, J Affect Disord. mai, vol.130, issue.3, pp.466-475, 2011.

I. Jalenques, G. Legrand, E. Vaille-perret, R. Tourtauchaux, and F. Galland, Therapeutic efficacy and safety of repetitive Transcranial Magnetic

, L'Encephale. juin, vol.36, issue.2, pp.105-118, 2010.

Z. Nahas, X. Li, F. A. Kozel, D. Mirzki, M. Memon et al., Safety and benefits of distance-adjusted prefrontal transcranial magnetic stimulation in depressed patients 55-75 years of age: a pilot study, Depress Anxiety, vol.19, issue.4, pp.249-56, 2004.

T. S. Kaster, Z. J. Daskalakis, Y. Noda, Y. Knyahnytska, J. Downar et al., Efficacy, tolerability, and cognitive effects of deep transcranial magnetic stimulation for late-life depression: a prospective randomized controlled trial, Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol, vol.43, issue.11, pp.2231-2239, 2018.

H. Shin, Y. C. Youn, S. J. Chung, and Y. H. Sohn, Effect of high-frequency repetitive transcranial magnetic stimulation on major depressive disorder in patients with Parkinson's disease, J Neurol. juill, vol.263, issue.7, pp.1442-1450, 2016.

A. Makkos, E. Pál, Z. Aschermann, J. Janszky, É. Balázs et al., High-Frequency Repetitive Transcranial Magnetic Stimulation Can Improve Depression in Parkinson's Disease: A Randomized, Double-Blind, Placebo-Controlled Study, Neuropsychobiology, vol.73, issue.3, pp.169-77, 2016.

X. Dong, L. Yan, L. Huang, X. Guan, C. Dong et al., Repetitive transcranial magnetic stimulation for the treatment of Alzheimer's disease: A systematic review and meta-analysis of randomized controlled trials, PloS One, vol.13, issue.10, p.205704, 2018.

Y. Lin, W. Jiang, P. Shan, M. Lu, T. Wang et al., The role of repetitive transcranial magnetic stimulation (rTMS) in the treatment of cognitive impairment in patients with Alzheimer's disease: A systematic review and meta-analysis, J Neurol Sci. 15 mars, vol.398, pp.184-91, 2019.

C. Cheng, C. Wong, K. K. Lee, A. Chan, J. Yeung et al., Effects of repetitive transcranial magnetic stimulation on improvement of cognition in elderly patients with cognitive impairment: a systematic review and meta-analysis, Int J Geriatr Psychiatry. janv, vol.33, issue.1, pp.1-13, 2018.

N. B. Bosaipo, M. P. Foss, A. H. Young, and M. F. Juruena, Neuropsychological changes in melancholic and atypical depression: A systematic review, Neurosci Biobehav Rev. févr, vol.73, pp.309-334, 2017.

C. Yang, K. M. Tiemessen, F. J. Bosker, K. J. Wardenaar, J. Lie et al., Interleukin, tumor necrosis factor-? and C-reactive protein profiles in melancholic and nonmelancholic depression: A systematic review, J Psychosom Res, vol.111, pp.58-68, 2018.

M. F. Juruena, M. Bocharova, B. Agustini, and A. H. Young, Atypical depression and nonatypical depression: Is HPA axis function a biomarker? A systematic review, J Affect Disord, vol.233, pp.45-67, 2018.

E. M. Veltman, F. Lamers, H. C. Comijs, M. De-waal, M. L. Stek et al., Depressive subtypes in an elderly cohort identified using latent class analysis, J Affect Disord, vol.15, pp.123-153, 2017.

F. Lamers, P. De-jonge, W. A. Nolen, J. H. Smit, F. G. Zitman et al., Identifying Depressive Subtypes in a Large Cohort Study: Results From the Netherlands Study of Depression and Anxiety (NESDA), J Clin Psychiatry. 15 déc, vol.71, issue.12, pp.1582-1591, 2010.

L. Liao, Z. Wu, D. Mellor, D. Peng, C. Zhang et al., Subtypes of treatment-resistant depression determined by a latent class analysis in a Chinese clinical population, J Affect Disord. 15 avr, vol.249, pp.82-91, 2019.

H. M. Van-loo, R. Wanders, K. J. Wardenaar, and E. I. Fried, Problems with latent class analysis to detect data-driven subtypes of depression, Mol Psychiatry, vol.23, issue.3, pp.495-501, 2018.

C. M. Ulbricht, S. A. Chrysanthopoulou, L. Levin, and K. L. Lapane, The use of latent class analysis for identifying subtypes of depression: A systematic review, Psychiatry Res, vol.266, pp.228-274, 2018.

A. T. Drysdale, L. Grosenick, J. Downar, K. Dunlop, F. Mansouri et al., Restingstate connectivity biomarkers define neurophysiological subtypes of depression, Nat Med. janv, vol.23, issue.1, pp.28-38, 2017.